|
Coordination of Clinical Studies of Cell-Based Therapies
LBS has unmatched experience in supporting blood product collection for clinical studies for cell-based therapies:
- Served as national coordinator for autologous whole blood collection for a phase II clinical trial of a therapeutic vaccine for multiple sclerosis
- Managed enrollment of subjects at 35 clinical sites across the U.S.
- Ensured that sponsor completed enrollment of targeted number of subjects (150) in less than 12 months
LBS is currently serving in a similar role for an open label follow-on study of this therapeutic vaccine. |
